Month: May 2020

Vitamin B3 revitalizes energy metabolism in muscle disease

Scientists have reported that vitamin B3, niacin, has therapeutic effect in progressive muscle disease. Niacin delayed disease progression in patients with mitochondrial myopathy, a progressive disease with no previous curative treatments. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the Future of Human Potential, […]

Published on May 17, 2020

Neuroimmunomodulatory and Neuroprotective Effects of the Flavonoid Apigenin in in vitro Models of Neuroinflammation Associated With Alzheimer’s Disease

Neurodegenerative disorders (ND) are characterized by the progressive and irreversible loss of neurons. Alzheimer’s Disease (AD) is the most incident age-related ND, in which the presence of a chronic inflammatory compound seems to be related to its pathogenesis. Different stimuli in the central nervous system (CNS) can induce activation, proliferation, and changes in phenotype and […]

Published on May 16, 2020

Beyond the Average View of Dopamine

Dopamine (DA) responses are synonymous with the ‘reward prediction error’ of reinforcement learning (RL), and are thought to update neural estimates of expected value. A recent study by Dabney et al. enriches this picture, demonstrating that DA neurons track variability in rewards, providing a readout of risk in the brain. Read Full Article (External Site) […]

Published on May 16, 2020